Biovica’s DiviTum TKa Shows Early Breast Cancer Response Signals
STOCKHOLM, Sweden, May 28, 2026 Biovica, a company focused on blood-based cancer monitoring technologies, announced new translational research published...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
STOCKHOLM, Sweden, May 28, 2026 Biovica, a company focused on blood-based cancer monitoring technologies, announced new translational research published...
MENLO PARK, Calif., May 27, 2026 Subtle Medical, a leading developer of AI-powered medical imaging software, has announced that...
AUSTIN, Texas, May 26, 2026 TOBY, Inc., a biotechnology company focused on non-invasive disease detection technologies, has announced that...
ABBOTT PARK, Ill., May 27, 2026 Abbott has announced that the updated American Cancer Society (ACS) colorectal cancer screening...
PORTLAND, Oregon, May 20, 2026 Araceli Biosciences announced the launch of Endeavor® Live Cell, a new ultra-high-throughput kinetic imaging...
VANCOUVER, British Columbia, May 20, 2026 Optimi Health Corp. has announced the pricing of an oversubscribed US$15 million underwritten...
BOSTON, Mass., May 20, 2026 The Paragon Institute has released a new scientific proposal highlighting the growing risks associated...
AMSTERDAM, Netherlands, May 18, 2026 Royal Philips has introduced SmartIQ, a breakthrough AI-enabled coronary imaging technology developed for its...
PARIS, France, May 20, 2026 Sensome continues to expand the clinical and commercial development of its smart guidewire platform...
SAN JOSE, Calif., May 14, 2026 Resurge Therapeutics announced positive clinical findings from two studies evaluating its proprietary IntraProstatic...
